Clinical Monitoring, Economics and Evaluation Unit, Agency for Clinical Innovation, Sydney, Australia.
Department of Public and Community Health, Murray State University, Murray, KY, USA.
Public Health Nutr. 2020 Sep;23(13):2395-2401. doi: 10.1017/S1368980020001068. Epub 2020 Jun 23.
To estimate the economic burden of overweight in Bangladesh.
We used data from Household Income and Expenditure Survey, 2010. A prevalence-based approach was used to calculate the population attributable fraction (PAF) for diseases attributable to overweight. Cost of illness methodology was used to calculate annual out of pocket (OOP) expenditure for each disease using nationally representative survey data. The cost attributable to overweight for each disease was estimated by multiplying the PAF by annual OOP expenditure. The total cost of overweight was estimated by adding PAF-weighted costs of treating the diseases.
Nationwide, covering the whole of Bangladesh.
Individuals whose BMI ≥ 25 kg/m2.
The total cost attributable to overweight in Bangladesh in 2010 was estimated at US$147·38 million. This represented about 0·13 % of Bangladesh's Gross Domestic Product and 3·69 % of total health care expenditure in 2010. The sensitivity analysis revealed that the total cost could be as high as US$334 million or as low as US$71 million.
A substantial amount of health care resource is devoted to the treatment of overweight-related diseases in Bangladesh. Effective national strategies for overweight prevention programme should be established and implemented.
估计超重给孟加拉国带来的经济负担。
我们使用了 2010 年家庭收入和支出调查的数据。采用基于流行率的方法计算了超重导致的可归因于疾病的人群归因分数(PAF)。采用疾病成本法,利用具有全国代表性的调查数据计算了每种疾病的年度自付费用(OOP)。每种疾病归因于超重的费用是通过将 PAF 乘以年度 OOP 支出来估算的。通过对治疗疾病的 PAF 加权费用进行加总,估算超重的总费用。
全国,覆盖整个孟加拉国。
BMI≥25kg/m2 的个人。
2010 年,孟加拉国归因于超重的总费用估计为 1.4738 亿美元。这占孟加拉国国内生产总值的 0.13%,占 2010 年总医疗保健支出的 3.69%。敏感性分析显示,总费用可能高达 3.34 亿美元,也可能低至 7100 万美元。
大量的医疗保健资源用于治疗孟加拉国与超重相关的疾病。应制定和实施有效的国家超重预防计划战略。